Kartik R
4 posts
Sep 04, 2024
3:44 AM
|
Hereditary Spherocytosis (HS) is a genetic disorder where red blood cells (RBCs) are abnormally spherical rather than disc-shaped. This defect causes the RBCs to be prematurely destroyed, leading to hemolytic anemia. The condition ranges in severity from mild to severe, with symptoms including anemia, jaundice, spleen enlargement, and gallstones. Genetic mutations impacting RBC membrane proteins, particularly ankyrin, are the primary cause.
Diagnosis combines clinical evaluation, lab tests, and genetic testing, which is crucial for confirming HS and guiding family screening. Treatment options include supportive care, blood transfusions, splenectomy, and cholecystectomy for gallstones. Genetic counseling is vital for understanding the disorder, assessing risks, and supporting families. Research into gene therapy and targeted treatments offers hope for improved management and potential cures. Continued advancements in these areas are crucial for enhancing the future outlook for individuals with Hereditary Spherocytosis
|
